Sexual Health & Medical Wellness Groundbreaking Vaccine Developed by Scripps Research Offers Broad Protection Against Fentanyl and Its Evolving Variants June 21, 2026 Susilo Ahmad Fentanyl, a synthetic opioid 50 to 100 times more potent than morphine, has rapidly ascended to become the deadliest drug in the United States, driving an unprecedented public health crisis.…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression June 2, 2026 Rebecca Shoemaker A groundbreaking discovery by researchers at McGill University and the Douglas Institute is poised to revolutionize our understanding of depression, identifying for the first time specific brain cell types that…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression May 22, 2026 Rebecca Shoemaker A groundbreaking study by researchers at McGill University and the Douglas Institute has unveiled a critical insight into the biological underpinnings of depression, identifying for the first time specific types…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression May 15, 2026 Rebecca Shoemaker Researchers at McGill University and the Douglas Institute have unveiled groundbreaking insights into the biological underpinnings of depression, identifying two distinct types of brain cells that exhibit altered function in…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression May 8, 2026 Rebecca Shoemaker Researchers at McGill University and the Douglas Institute have unveiled groundbreaking insights into the biological underpinnings of depression, identifying two distinct types of brain cells that exhibit altered functionality in…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression April 30, 2026 Rebecca Shoemaker A groundbreaking study by researchers at McGill University and the Douglas Institute has unveiled critical new insights into the biological underpinnings of depression, identifying two distinct types of brain cells…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression April 23, 2026 Rebecca Shoemaker Montreal, QC – In a significant advancement for understanding one of the world’s most pervasive mental health conditions, researchers at McGill University and the Douglas Institute have identified distinct functional…
Psychology & Intimacy Unlocking Psychedelic Potential: Scientists Engineer Psilocin Variants to Minimize Hallucinations April 3, 2026 Rebecca Shoemaker The quest to harness the therapeutic power of psilocybin, the well-known psychoactive compound in "magic mushrooms," has taken a significant stride forward. Researchers have successfully engineered novel psilocin derivatives that…
